LONDON – November 03, 2026 -- Clarivate Plc (NYSE: CLVT) closed the sale of its Life Sciences & Healthcare (LS&H) segment on October 6, 2026 for net cash proceeds of $488.4 million, and reported third-quarter organic revenue growth of 0.4% for continuing operations alongside a $80.8 million net loss driven by a goodwill impairment.

London – September 19, 2026 -- Clarivate Plc (NYSE: CLVT) named 22 researchers as its Citation Laureates 2026, identifying scientists whose work the company's Institute for Scientific Information (ISI) considers Nobel-class ahead of this year's Nobel Prize announcements. Since the program began in 2002, 89 previously named Citation Laureates have gone on to win Nobel Prizes.

Waltham, Mass. – September 18, 2026 -- Sales messages that tell B2B technology buyers they control a positive outcome hold attention 31% longer and produce 31% better recall than fear-based pitches, according to new neuroscience research from Allego, Inc. that challenges a nearly 50-year-old sales doctrine.